Mednet Logo
HomeAllergy & Immunology
Allergy & Immunology

Allergy & Immunology

Expert discussions on allergic conditions, immunodeficiencies, drug hypersensitivity, and immunotherapy approaches.

Recent Discussions

Do you use asthma or EoE dosing if initiating dupilumab in a patient who meets criteria for treatment for both disorders?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Children’s Hospital of Philadelphia (CHOP)

I would do the higher dose (EoE) if starting it for both.

How would you treat autologous GVHD after a thymic transplant but with no thymopoeisis?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Harvard Medical School

I would treat with steroids first, which are usually effective in auto-GvHD, and see how the response is. If it is insufficient, then you can add other immunosuppressive therapies.

Is omalizumab an option for a patient needing a specific antibiotic with an IgE-mediated reaction who continues to have reactions during a desensitization?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Scripps Clinic Medical Group

Omalizumab is FDA-approved for Asthma, Chronic spontaneous urticaria, chronic rhinosinusitis with nasal polyposis, and food allergy. It is a monoclonal antibody directed at IgE which will deplete circulating IgE and thus specific IgE on the mast cell and basophils will decrease. There is also likely...

Do you utilize urinary leukotrienes as a marker for initiation of montelukast?

1 Answers

Mednet Member
Mednet Member
Pulmonology · National Jewish Health

No, I don’t. It is not readily available clinically and has not been shown to be predictive of response.

Is separating dust mite and molds still necessary in light of increased addition of glycerol to IT mixtures?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology

We use mostly Greer products for mold and dust mite. Greer would note that mixing mold and dust mite is risky. Thus in practice, I do not mix dust mite and mold.Is it possible to do it? Yes, if stored in >10% glycerin as noted by Esch (2008). Dr. Macy, who I would argue is a more renown expert, seem...

In those patients who are initiated on omalizumab for multiple food allergies, once baked egg and baked milk are introduced into the diet, how long should you wait until a prepared egg and whole milk challenge is conducted?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · University of Maryland School of Medicine

In the OuTMATCH trial, patients were on omalizumab for 16-20 weeks before undergoing food challenges, but as in every situation, the clinical history is important. Skin testing and serum IgE testing may not be reliable on omalizumab, but if the patient is tolerating and eating baked and cooked egg a...

How do you perform patch testing in patients who are allergic to adhesives?

1 Answers

Mednet Member
Mednet Member
Dermatology · Case Western Reserve University

True allergy to the Scanpor tape most often used in patch testing is rare, even in patients allergic to colophony, p-tert-butyl phenol formaldehyde resin, rubber, or acrylate-based adhesives. What is more common, especially in atopic patients with microbial dysbiosis driving their dermatitis, is fla...

Do you recommend IM Kenalog injection for refractory CRSwNP in a patient already on maximal therapy?

2
1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Saint Louis University School of Medicine

For refractory CRSwP on maximal therapy, IM Kenalog would not be my drug of choice. I would rather suggest Dupixent. A number of published papers including some from Klaus Bachert clearly show the benefit of Dupixent in this subgroup of patients. IM kenalog might help for a short time, but Dupixent ...

How does omalizumab play a role in the armamentarium of atopic dermatitis?

1 Answers

Mednet Member
Mednet Member
Allergy & Immunology · Columbia University Medical Center

There are various reports (>30 citations) in the literature documenting Xolair efficacy in atopic dermatitis. The study designs include randomized placebo-controlled trials, retrospective case series, and case studies.A review of the literature published in 2019 by Holm & Thomsen, PMID 30717578 prov...

What are best practices in management of severe acute infusion reaction from infliximab?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Dartmouth-Hitchcock Medical Center

Severe infusion reactions to infliximab are not typically IgE-mediated. The presumption is that it is ‘anaphylactoid’ due to IgG antibodies directed against the mouse chimeric proteins in the molecule. Stopping the infusion is essential (at least temporarily) and administering antihistamines such as...